Clinical Trials Browser

Phase 2 × INDUSTRY × Meningeal Carcinomatosis × Clear all

NCT05146219 2024-12-30

Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation

Phase 2 Completed

Brain Neoplasms, Meningeal Carcinomatosis